This book explores whether the judicial developments related to the Supplementary
Protection Certificate (SPC) regulation correspond to the objectives of the European
legislator. Examining the role of SPCs for medicinal products in the European patent
system, it highlights both the jurisprudence of the Court of Justice of the European
Union and the respective judgements of the member states’ national courts.